<DOC>
	<DOCNO>NCT00500591</DOCNO>
	<brief_summary>It known woman obese high risk endometrial cancer ( cancer line uterus womb ) . The goal clinical research study find common abnormality endometrium woman consider obese find abnormality less common woman consider thin . Researchers would like learn obese patient symptom ( like irregular menstrual cycle ) may mean could abnormality present . Researchers would also like know obese woman access regular female exam whether routinely go primary care doctor .</brief_summary>
	<brief_title>Prevalence Endometrial Abnormalities In Obese Women</brief_title>
	<detailed_description>Women study ask complete three different part study . All three part study do one visit gynecology center . First , ask complete survey/questionnaire give researcher information background , weight history , gynecologic , medical history . You assist research nurse completion questionnaire expect take 30 minute . Second , ask blood sample drawn . About 2 tablespoon blood drawn . This blood use look different hormone level may relate risk endometrial abnormality . Third , endometrial biopsy perform one doctor run study . This require full pelvic exam ( much like pap smear ) , include look cervix ( mouth womb ) put small pipelle ( straw ) womb collect tissue sample . This procedure routinely do office . You require take medication prior procedure receive prescription pain medication procedure complete . Completion three part study may take one two hour . You physician notify endometrial biopsy result . This investigational study . Up 200 participant enrol study . All enrol MD Anderson .</detailed_description>
	<mesh_term>Congenital Abnormalities</mesh_term>
	<criteria>1 . Patients must measure BMI great equal 30 kg/m2 ( obese ) less equal 25 kg/m2 ( lean ) time enrollment . 2 . Patients must age 30 55 year old time enrollment . 3 . Patients must take birth control ( include pill , patch , injectables ) least three month prior enrollment . 4 . Patients may pregnant time enrollment ( define negative urine pregnancy test ) . 5 . Patients must sign informed consent indicate aware investigational nature study . 6 . Patients history nonmetastatic cancer may include undergone cancer treatment least six month prior enrollment . 1 . Patients prior hysterectomy . 2 . Patients pregnant positive pregnancy test . 3 . Patients prior history endometrial hyperplasia endometrial cancer . 4 . Patients currently birth control ( include pill , patch , injectable birth control ) . 5 . Patients postmenopausal ( menstrual cycle great equal one year ) . 6 . Patients ever selective estrogen receptor modulators ( SERMs ) past include Tamoxifen Raloxifene . 7 . Patients history metastatic cancer ( type ) . 8 . Patients history nonmetastatic cancer currently undergo therapy cancer receive therapy within six month enrollment . 9 . Patients history nonmetastatic cancer receive type hormonal therapy include limited aromatase inhibitor , GNRHagonists , Zoladex . 10 . Patients prior radiation pelvis . 11 . Patients psychiatric disorder would interfere consent .</criteria>
	<gender>Female</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Endometrial Abnormalities</keyword>
	<keyword>Endometrial Cancer</keyword>
	<keyword>Obesity</keyword>
	<keyword>Survey</keyword>
	<keyword>Questionnaire</keyword>
</DOC>